IDO1 and psoriasis: Studies on kynurenine pathway in psoriasis are very limited but demonstrate upregulation of KP in psoriasis patients and an increased activity of two enzymes—indoleamine 2,3-dioxygenase (IDO) and L-kynureninase (KYNU)—in psoriatic lesions [14].